Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Definitive surgical management of renal cell carcinoma

Jerome P Richie, MD, FACS
Section Editor
Michael B Atkins, MD
Deputy Editors
Wenliang Chen, MD, PhD
Michael E Ross, MD


Renal cell carcinoma (RCC) is responsible for 80 to 85 percent of all primary renal neoplasms. Over 60,000 people are diagnosed with RCC on an annual basis in the United States, with almost 14,000 deaths expected each year. In Europe in 2012, there were 115,000 cases and 49,000 deaths [1].

For patients with localized RCC and select patients with advanced RCC, surgery can be curative. This topic will review the role of surgery in the definitive management of RCC.

Related topics include:

(See "Overview of the treatment of renal cell carcinoma".)

(See "Radiofrequency ablation and cryoablation for renal cell carcinoma".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 30, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49:1374.
  2. Colombo JR Jr, Haber GP, Jelovsek JE, et al. Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. Urology 2008; 71:1149.
  3. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011; 59:543.
  4. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7:735.
  5. Mitchell RE, Lee BT, Cookson MS, et al. Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients. Cancer 2009; 115:2447.
  6. O'Malley RL, Godoy G, Kanofsky JA, Taneja SS. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 2009; 181:2009.
  7. Siemer S, Lehmann J, Kamradt J, et al. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol 2004; 171:2155.
  8. Kuczyk M, Wegener G, Jonas U. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol 2005; 48:252.
  9. ROBSON CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963; 89:37.
  10. Waters WB, Richie JP. Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol 1979; 122:306.
  11. CHUTE R, SOUTTER L, KERR WS Jr. The value of the thoracoabdominal incision in the removal of kidney tumors. N Engl J Med 1949; 241:951.
  12. Cohen DD, Matin SF, Steinberg JR, et al. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence. J Urol 2005; 173:1487.
  13. Gong EM, Lyon MB, Orvieto MA, et al. Laparoscopic radical nephrectomy: comparison of clinical Stage T1 and T2 renal tumors. Urology 2006; 68:1183.
  14. Burgess NA, Koo BC, Calvert RC, et al. Randomized trial of laparoscopic v open nephrectomy. J Endourol 2007; 21:610.
  15. Berger A, Brandina R, Atalla MA, et al. Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. J Urol 2009; 182:2172.
  16. Jeong IG, Khandwala YS, Kim JH, et al. Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy With Perioperative Outcomes and Health Care Costs, 2003 to 2015. JAMA 2017; 318:1561.
  17. Asimakopoulos AD, Miano R, Annino F, et al. Robotic radical nephrectomy for renal cell carcinoma: a systematic review. BMC Urol 2014; 14:75.
  18. MacLennan S, Imamura M, Lapitan MC, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 2012; 62:1097.
  19. Mashni JW, Assel M, Maschino A, et al. New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors. Urology 2015; 86:1137.
  20. Lane BR, Gill IS. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 2010; 183:473.
  21. Ono Y, Hattori R, Gotoh M, et al. Laparoscopic radical nephrectomy for renal cell carcinoma: the standard of care already? Curr Opin Urol 2005; 15:75.
  22. Benway BM, Bhayani SB, Rogers CG, et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol 2009; 182:866.
  23. Wu Z, Li M, Liu B, et al. Robotic versus open partial nephrectomy: a systematic review and meta-analysis. PLoS One 2014; 9:e94878.
  24. Raz O, Mendlovic S, Leibovici D, et al. The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgery. J Urol 2007; 178:1892.
  25. Lane BR, Tiong HY, Campbell SC, et al. Management of the adrenal gland during partial nephrectomy. J Urol 2009; 181:2430.
  26. Yossepowitch O, Thompson RH, Leibovich BC, et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008; 179:2158.
  27. Bensalah K, Pantuck AJ, Rioux-Leclercq N, et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2010; 57:466.
  28. Shah PH, Moreira DM, Okhunov Z, et al. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. J Urol 2016; 196:327.
  29. Venigalla S, Wu G, Miyamoto H. The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: a clinicopathologic study of 433 cases. Clin Genitourin Cancer 2013; 11:527.
  30. Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171:2181.
  31. Pahernik S, Roos F, Hampel C, et al. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 2006; 175:2027.
  32. Crépel M, Jeldres C, Perrotte P, et al. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Urology 2010; 75:271.
  33. Pahernik S, Roos F, Röhrig B, et al. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 2008; 179:71.
  34. Thompson RH, Siddiqui S, Lohse CM, et al. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 2009; 182:2601.
  35. Crispen PL, Breau RH, Allmer C, et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 2011; 59:18.
  36. Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011; 60:1212.
  37. Blom JH, van Poppel H, Maréchal JM, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 2009; 55:28.
  38. Studer UE, Birkhäuser FD. Lymphadenectomy combined with radical nephrectomy: to do or not to do? Eur Urol 2009; 55:35.
  39. Whitson JM, Harris CR, Reese AC, Meng MV. Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 2011; 185:1615.
  40. Gershman P, Thompson RH, Moreira DM, et al. Radical nephrectomy with or without lymph node dissection for nonmetastatic renal cell carcinoma: a propensity score-based analysis. Eur Urol 2016.
  41. Mehta V, Mudaliar K, Ghai R, et al. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat. Arch Pathol Lab Med 2013; 137:1584.
  42. McKiernan J, Yossepowitch O, Kattan MW, et al. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 2002; 60:1003.
  43. Patel MI, Simmons R, Kattan MW, et al. Long-term follow-up of bilateral sporadic renal tumors. Urology 2003; 61:921.
  44. Bazeed MA, Schärfe T, Becht E, et al. Conservative surgery of renal cell carcinoma. Eur Urol 1986; 12:238.
  45. Fadahunsi AT, Sanford T, Linehan WM, et al. Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol 2011; 185:49.
  46. Stormont TJ, Bilhartz DL, Zincke H. Pitfalls of "bench surgery" and autotransplantation for renal cell carcinoma. Mayo Clin Proc 1992; 67:621.
  47. Lardas M, Stewart F, Scrimgeour D, et al. Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. Eur Urol 2016; 70:265.
  48. Sigman DB, Hasnain JU, Del Pizzo JJ, Sklar GN. Real-time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy. J Urol 1999; 161:36.
  49. Chiappini B, Savini C, Marinelli G, et al. Cavoatrial tumor thrombus: single-stage surgical approach with profound hypothermia and circulatory arrest, including a review of the literature. J Thorac Cardiovasc Surg 2002; 124:684.
  50. Manassero F, Mogorovich A, Di Paola G, et al. Renal cell carcinoma with caval involvement: contemporary strategies of surgical treatment. Urol Oncol 2011; 29:745.
  51. Welz A, Schmeller N, Schmitz C, et al. Resection of hypernephromas with vena caval or right atrial tumor extension using extracorporeal circulation and deep hypothermic circulatory arrest: a multidisciplinary approach. Eur J Cardiothorac Surg 1997; 12:127.
  52. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 2003; 169:909.
  53. Tsuji Y, Goto A, Hara I, et al. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. J Vasc Surg 2001; 33:789.
  54. Shuch B, Larochelle JC, Onyia T, et al. Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol 2009; 181:492.
  55. Kalman D, Varenhorst E. The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol 1999; 33:162.
  56. May M, Brookman-Amissah S, Pflanz S, et al. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol 2009; 82:724.
  57. Carini M, Minervini A, Masieri L, et al. Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience. Eur Urol 2006; 50:1263.
  58. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer 2008; 113:2671.
  59. Psutka SP, Feldman AS, McDougal WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63:486.
  60. Tanagho YS, Bhayani SB, Kim EH, Figenshau RS. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol 2013; 27:1477.
  61. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182:1271.